BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)
CUSIP: 09058V103
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 210,587,372
- Total 13F shares
- 174,092,743
- Share change
- +3,616,989
- Total reported value
- $1,225,943,210
- Put/Call ratio
- 21%
- Price per share
- $7.04
- Number of holders
- 233
- Value change
- +$15,794,543
- Number of buys
- 124
- Number of sells
- 84
Quarterly Holders Quick Answers
What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09058V103:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
7%
|
14,826,113
|
$123,649,783 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7%
|
14,824,798
|
$123,638,815 | — | 31 Mar 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
6%
|
12,710,818
|
$106,008,222 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
5.4%
|
11,389,623
|
$94,989,576 | — | 31 Mar 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.9%
|
10,420,000
|
$86,902,800 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
2.7%
|
5,618,372
|
$46,857,222 | — | 31 Mar 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.4%
|
4,967,837
|
$41,431,761 | — | 31 Mar 2023 | |
| Eversept Partners, LP |
13F
|
Company |
2.1%
|
4,520,724
|
$37,702,838 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.1%
|
4,437,329
|
$37,007,000 | — | 31 Mar 2023 | |
| Fisher Asset Management, LLC |
13F
|
Company |
2%
|
4,293,396
|
$35,806,922 | — | 31 Mar 2023 | |
| RP Management, LLC |
13F
|
Company |
1.8%
|
3,846,154
|
$32,076,924 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
3,653,556
|
$30,470,668 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.7%
|
3,614,333
|
$30,143,536 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
1.5%
|
3,167,510
|
$26,417,033 | — | 31 Mar 2023 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
1.4%
|
2,887,739
|
$24,084,000 | — | 31 Mar 2023 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.3%
|
2,837,924
|
$23,668,286 | — | 31 Mar 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.3%
|
2,765,000
|
$23,060,100 | — | 31 Mar 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.2%
|
2,603,931
|
$21,717,000 | — | 31 Mar 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.1%
|
2,334,085
|
$19,466,269 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1%
|
2,202,712
|
$18,370,618 | — | 31 Mar 2023 | |
| PFM Health Sciences, LP |
13F
|
Company |
1%
|
2,162,411
|
$18,034,508 | — | 31 Mar 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.97%
|
2,034,343
|
$16,966,421 | — | 31 Mar 2023 | |
| BRAIDWELL LP |
13F
|
Company |
0.92%
|
1,945,134
|
$16,222,418 | — | 31 Mar 2023 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.88%
|
1,844,074
|
$15,379,577 | — | 31 Mar 2023 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.87%
|
1,837,854
|
$15,327,000 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.84%
|
1,763,099
|
$14,704,246 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.76%
|
1,610,670
|
$13,432,988 | — | 31 Mar 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.76%
|
1,600,000
|
$13,344,000 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.68%
|
1,423,120
|
$11,868,821 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.64%
|
1,340,318
|
$11,178,252 | — | 31 Mar 2023 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.6%
|
1,268,852
|
$10,582,226 | — | 31 Mar 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.58%
|
1,221,681
|
$10,189,000 | — | 31 Mar 2023 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.55%
|
1,163,535
|
$9,703,882 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.54%
|
1,126,706
|
$9,396,728 | — | 31 Mar 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.52%
|
1,102,889
|
$9,198,094 | — | 31 Mar 2023 | |
| Prosight Management, LP |
13F
|
Company |
0.51%
|
1,074,593
|
$8,962,105 | — | 31 Mar 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.47%
|
1,000,000
|
$8,340,000 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.43%
|
905,070
|
$7,548,284 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.42%
|
884,863
|
$7,379,757 | — | 31 Mar 2023 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.42%
|
874,840
|
$7,296,165 | — | 31 Mar 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.39%
|
820,521
|
$6,843,145 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.38%
|
796,299
|
$6,641,000 | — | 31 Mar 2023 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.37%
|
775,000
|
$6,463,500 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.33%
|
703,173
|
$5,864,464 | — | 31 Mar 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.33%
|
701,580
|
$5,851,177 | — | 31 Mar 2023 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.33%
|
691,883
|
$5,770,304 | — | 31 Mar 2023 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
673,265
|
$5,615,030 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.32%
|
670,608
|
$5,592,871 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.31%
|
659,467
|
$5,499,955 | — | 31 Mar 2023 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.29%
|
604,411
|
$5,040,787 | — | 31 Mar 2023 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q2 2023
As of 30 Jun 2023,
BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by
233 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
174,092,743 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, STATE STREET CORP, Avoro Capital Advisors LLC, Assenagon Asset Management S.A., MILLENNIUM MANAGEMENT LLC, PICTET ASSET MANAGEMENT SA, Fisher Asset Management, LLC, and Point72 Asset Management, L.P..
This page lists
233
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
237
Q2 2023 holders
233
Holder diff
-4
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.